Skip to main content

HUTCHMED (China) Ltd

HCM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001648257

No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.

Other share classesHMDCF

Q4 2024 vs. Q3 2024

How the institutions holding HUTCHMED (China) Ltd changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of HCM: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders6670+4
Shares7.29M6.90M−395.9K (−5.4%)
Value$141.4M$99.3M−$42.1M (−29.8%)

New holders (11)

Institutions that held HUTCHMED (China) Ltd at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to HCM in Q4 2024
InstitutionSharesValue% of portfolio
XY Capital Ltd46,676$672.6K0.75%
Abc Arbitrage SA34,710$500.2K0.07%
Marshall Wace, LLP18,102$260.9K0.00%
Old Mission Capital LLC15,956$229.9K0.01%
Barometer Capital Management Inc.10,900$186.6K0.07%
Aquatic Capital Management LLC1,022$14.7K0.00%
GF Fund Management Co. Ltd.651$9.38K0.00%
Simplex Trading, LLC391$5.00K0.00%
Creekmur Asset Management LLC19$2740.00%
Russell Investments Group, Ltd.16$2310.00%
IFP Advisors, Inc0$1730.00%

Sold out (7)

Institutions that held HUTCHMED (China) Ltd at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of HCM in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Bellevue Group AG24,015$469.0K
Point72 Hong Kong Ltd21,562$421.1K
Two Sigma Advisers, LP10,800$210.9K
Rathbone Brothers plc10,450$204.1K
Nisa Investment Advisors, LLC200$3.91K
Royal Bank of Canada100$2.00K
CIBC Private Wealth Group, LLC67$1.31K